InvestorsObserver
×
News Home

Is Day One Biopharmaceuticals Inc (DAWN) Stock a Good Value?

Thursday, May 26, 2022 01:36 PM | InvestorsObserver Analysts

Mentioned in this article

Is Day One Biopharmaceuticals Inc (DAWN) Stock a Good Value?

Day One Biopharmaceuticals Inc (DAWN) stock is down -77.37% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives DAWN stock a score of 25 out of a possible 100.

That rank is chiefly influenced by a long-term technical score of 3. DAWN's rank also includes a short-term technical score of 5. The fundamental score for DAWN is 65. In addition to the average rating from Wall Street analysts, DAWN stock has a mean target price of $32.67. This means analysts expect the stock to climb 457.44% over the next 12 months.
Overall Score - 25
DAWN has an Overall Score of 25. Find out what this means to you and get the rest of the rankings on DAWN!

What's Happening with DAWN Stock Today

Day One Biopharmaceuticals Inc (DAWN) stock is down -4.95% while the S&P 500 is higher by 2.17% as of 1:34 PM on Thursday, May 26. DAWN is down -$0.30 from the previous closing price of $6.16 on volume of 387,176 shares. Over the past year the S&P 500 is lower by -3.23% while DAWN is down -77.37%. DAWN lost -$3.00 per share in the over the last 12 months. Click Here to get the full Stock Report for Day One Biopharmaceuticals Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App